MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALMKT - FR0010609263 - Common Stock
0.0798 EUR
+0 (+1.66%)
Taking everything into account, ALMKT scores 2 out of 10 in our fundamental rating. ALMKT was compared to 65 industry peers in the Health Care Equipment & Supplies industry. ALMKT may be in some trouble as it scores bad on both profitability and health. ALMKT has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ALMKT has reported negative net income.
ALMKT had a negative operating cash flow in the past year.
In the past 5 years ALMKT always reported negative net income.
In the past 5 years ALMKT always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of ALMKT (-76.92%) is worse than 87.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -76.92% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-45.07%
ROA(5y)-50.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 31.67%, ALMKT is doing worse than 83.08% of the companies in the same industry.
ALMKT's Gross Margin has improved in the last couple of years.
ALMKT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMKT has more shares outstanding
The number of shares outstanding for ALMKT has been increased compared to 5 years ago.
ALMKT has a worse debt/assets ratio than last year.
2.2 Solvency
ALMKT has an Altman-Z score of -7.66. This is a bad value and indicates that ALMKT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALMKT (-7.66) is worse than 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.66 |
ROIC/WACCN/A
WACC6.74%
2.3 Liquidity
ALMKT has a Current Ratio of 0.23. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKT's Current ratio of 0.23 is on the low side compared to the rest of the industry. ALMKT is outperformed by 90.77% of its industry peers.
A Quick Ratio of 0.12 indicates that ALMKT may have some problems paying its short term obligations.
ALMKT has a Quick ratio of 0.12. This is amonst the worse of the industry: ALMKT underperforms 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.12 |
3. Growth
3.1 Past
ALMKT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.00%.
Looking at the last year, ALMKT shows a very negative growth in Revenue. The Revenue has decreased by -26.96% in the last year.
The Revenue has been growing slightly by 0.60% on average over the past years.
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.16%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
3.2 Future
The Earnings Per Share is expected to grow by 23.86% on average over the next years. This is a very strong growth
ALMKT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.82% yearly.
EPS Next Y50%
EPS Next 2Y74.64%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y38.6%
Revenue Next 3Y26.82%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
ALMKT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALMKT is valuated cheaply with a Price/Forward Earnings ratio of 0.74.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALMKT indicates a rather cheap valuation: ALMKT is cheaper than 100.00% of the companies listed in the same industry.
ALMKT is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.74 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALMKT's earnings are expected to grow with 23.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.64%
EPS Next 3Y23.86%
5. Dividend
5.1 Amount
No dividends for ALMKT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:ALMKT (1/7/2026, 7:00:00 PM)
0.0798
+0 (+1.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners6.18%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap13.96M
Revenue(TTM)7.66M
Net Income(TTM)-10.00M
Analysts86.67
Price Target0.51 (539.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-400%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.74 | ||
| P/S | 1.82 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.16
EYN/A
EPS(NY)0.11
Fwd EY135.53%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.04
BVpS-0.17
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -76.92% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.67% | ||
| FCFM | N/A |
ROA(3y)-45.07%
ROA(5y)-50.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
F-Score3
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 12.57% | ||
| Cap/Sales | 3.14% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.12 | ||
| Altman-Z | -7.66 |
F-Score3
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)16.7%
Cap/Depr(5y)36.43%
Cap/Sales(3y)2.79%
Cap/Sales(5y)7.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.16%
EPS Next Y50%
EPS Next 2Y74.64%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
Revenue Next Year0%
Revenue Next 2Y38.6%
Revenue Next 3Y26.82%
Revenue Next 5YN/A
EBIT growth 1Y-594.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.14%
EBIT Next 3Y27.11%
EBIT Next 5YN/A
FCF growth 1Y-3923.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2465%
OCF growth 3YN/A
OCF growth 5YN/A
MAUNA KEA TECHNOLOGIES / ALMKT.PA FAQ
What is the ChartMill fundamental rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA.
What is the valuation status of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to MAUNA KEA TECHNOLOGIES (ALMKT.PA). This can be considered as Fairly Valued.
How profitable is MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
MAUNA KEA TECHNOLOGIES (ALMKT.PA) has a profitability rating of 1 / 10.
What is the financial health of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
The financial health rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is 0 / 10.